| UniProt ID | DMB_HUMAN | |
|---|---|---|
| UniProt AC | P28068 | |
| Protein Name | HLA class II histocompatibility antigen, DM beta chain | |
| Gene Name | HLA-DMB | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 263 | |
| Subcellular Localization |
Late endosome membrane Single-pass type I membrane protein . Lysosome membrane Single-pass type I membrane protein . Localizes to late endocytic compartment. Associates with lysosome membranes. |
|
| Protein Description | Plays a critical role in catalyzing the release of class II-associated invariant chain peptide (CLIP) from newly synthesized MHC class II molecules and freeing the peptide binding site for acquisition of antigenic peptides. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO.. | |
| Protein Sequence | MITFLPLLLGLSLGCTGAGGFVAHVESTCLLDDAGTPKDFTYCISFNKDLLTCWDPEENKMAPCEFGVLNSLANVLSQHLNQKDTLMQRLRNGLQNCATHTQPFWGSLTNRTRPPSVQVAKTTPFNTREPVMLACYVWGFYPAEVTITWRKNGKLVMPHSSAHKTAQPNGDWTYQTLSHLALTPSYGDTYTCVVEHIGAPEPILRDWTPGLSPMQTLKVSVSAVTLGLGLIIFSLGVISWRRAGHSSYTPLPGSNYSEGWHIS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 110 | N-linked_Glycosylation | PFWGSLTNRTRPPSV CCCHHCCCCCCCCCE | 48.93 | 16335952 | |
| 216 | Phosphorylation | PGLSPMQTLKVSVSA CCCCHHHCEEEHHHH | 23.46 | - | |
| 239 | Phosphorylation | IFSLGVISWRRAGHS HHHHCEEEHHCCCCC | 16.48 | 24719451 | |
| 246 | Phosphorylation | SWRRAGHSSYTPLPG EHHCCCCCCCCCCCC | 24.91 | 27080861 | |
| 247 | Phosphorylation | WRRAGHSSYTPLPGS HHCCCCCCCCCCCCC | 27.61 | 27080861 | |
| 248 | Phosphorylation | RRAGHSSYTPLPGSN HCCCCCCCCCCCCCC | 18.52 | 30108239 | |
| 249 | Phosphorylation | RAGHSSYTPLPGSNY CCCCCCCCCCCCCCC | 21.94 | 27080861 | |
| 254 | Phosphorylation | SYTPLPGSNYSEGWH CCCCCCCCCCCCCCC | 30.56 | 27080861 | |
| 256 | Phosphorylation | TPLPGSNYSEGWHIS CCCCCCCCCCCCCCC | 15.14 | 27642862 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DMB_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DMB_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DMB_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MDM2_HUMAN | MDM2 | physical | 21988832 | |
| TEAD1_HUMAN | TEAD1 | physical | 21988832 | |
| DHRS7_HUMAN | DHRS7 | physical | 26186194 | |
| AP3M1_HUMAN | AP3M1 | physical | 26186194 | |
| PHOP1_HUMAN | PHOSPHO1 | physical | 26186194 | |
| AP3M1_HUMAN | AP3M1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASSSPECTROMETRY. | |